Literature DB >> 24527995

Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure.

Minetaro Arita1.   

Abstract

Studies on anti-picornavirus compounds have revealed an essential role of a novel cellular pathway via host phosphatidylinositol-4 kinase III beta (PI4KB) and oxysterol-binding protein (OSBP) family I in poliovirus (PV) replication. However, the molecular role for this pathway in PV replication has yet to be determined. Here, viral and host proteins modulating production of phosphatidylinositol 4-phosphate (PI4P) and accumulation of unesterified cholesterol (UC) in cells were analyzed and the role of the PI4KB/OSBP pathway in PV replication characterized. Virus protein 2BC was identified as a novel interactant of PI4KB. PI4KB and VCP/p97 bind to a partially overlapped region of 2BC with different sensitivity to a 2C inhibitor. Production of PI4P and accumulation of UC were enhanced by virus protein 2BC, but suppressed by virus proteins 3A and 3AB. In PV-infected cells, a PI4KB inhibitor suppressed production of PI4P, and both a PI4KB inhibitor and an OSBP ligand suppressed accumulation of UC on virus-induced membrane structure. Inhibition of PI4KB activity caused dissociation of OSBP from virus-induced membrane structure in PV-infected cells. Synthesis of viral nascent RNA in PV-infected cells was not affected in the presence of PI4KB inhibitor and OSBP ligand; however, transient pre-treatment of PV-infected cells with these inhibitors suppressed viral RNA synthesis. These results suggest that virus proteins modulate PI4KB activity and provide PI4P for recruitment of OSBP to accumulate UC on virus-induced membrane structure for formation of a virus replication complex.
© 2014 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  enterovirus; oxysterol-binding protein; phosphatidylinositol-4 kinase III beta; replication

Mesh:

Substances:

Year:  2014        PMID: 24527995     DOI: 10.1111/1348-0421.12144

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  58 in total

Review 1.  Lipids and RNA virus replication.

Authors:  Kouacou V Konan; Lorena Sanchez-Felipe
Journal:  Curr Opin Virol       Date:  2014-09-28       Impact factor: 7.090

Review 2.  Picornavirus morphogenesis.

Authors:  Ping Jiang; Ying Liu; Hsin-Chieh Ma; Aniko V Paul; Eckard Wimmer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

3.  Hepatitis C virus replication compartment formation: mechanism and drug target.

Authors:  Vineela Chukkapalli; Glenn Randall
Journal:  Gastroenterology       Date:  2014-03-25       Impact factor: 22.682

Review 4.  Rewiring of cellular membrane homeostasis by picornaviruses.

Authors:  George A Belov; Elizabeth Sztul
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

5.  Model of OSBP-Mediated Cholesterol Supply to Aichi Virus RNA Replication Sites Involving Protein-Protein Interactions among Viral Proteins, ACBD3, OSBP, VAP-A/B, and SAC1.

Authors:  Kumiko Ishikawa-Sasaki; Shigeo Nagashima; Koki Taniguchi; Jun Sasaki
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 6.  Bridging the molecular and biological functions of the oxysterol-binding protein family.

Authors:  Antonietta Pietrangelo; Neale D Ridgway
Journal:  Cell Mol Life Sci       Date:  2018-03-13       Impact factor: 9.261

7.  GBF1- and ACBD3-independent recruitment of PI4KIIIβ to replication sites by rhinovirus 3A proteins.

Authors:  Cristina M Dorobantu; Lauren A Ford-Siltz; Simone P Sittig; Kjerstin H W Lanke; George A Belov; Frank J M van Kuppeveld; Hilde M van der Schaar
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

Review 8.  25-Hydroxycholesterols in innate and adaptive immunity.

Authors:  Jason G Cyster; Eric V Dang; Andrea Reboldi; Tangsheng Yi
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

9.  A Single Point Mutation in the Rhinovirus 2B Protein Reduces the Requirement for Phosphatidylinositol 4-Kinase Class III Beta in Viral Replication.

Authors:  Pascal S Roulin; Luca P Murer; Urs F Greber
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

10.  Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.

Authors:  Sabine M G van der Sanden; Weilin Wu; Naomi Dybdahl-Sissoko; William C Weldon; Paula Brooks; Jason O'Donnell; Les P Jones; Cedric Brown; S Mark Tompkins; M Steven Oberste; Jon Karpilow; Ralph A Tripp
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.